openPR Logo
Press release

Astigmatism Market Poised for Robust Growth in the 7MM | DelveInsight

04-14-2025 02:14 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Astigmatism Market Poised for Robust Growth in the 7MM |

The Astigmatism companies in the market include - Johnson & Johnson, HOYA, Alcon, Lenstec Optical Group, HumanOptics, Carl Zeiss Meditec, Bausch + Lomb, Rayner, STAAR Surgical, EyeKon, Care Group, Morcher, Ophtec, Hanita Lenses, Omni Lens Pvt Ltd, Aurolab, SIFI, PhysIOL, and Excellent Hicare Pvt Ltd, and others.

The astigmatism market is witnessing significant growth in 7MM (United States, Canada, France, Germany, Italy, Spain, and the United Kingdom), driven by a combination of demographic trends, advancements in vision correction technologies, and an increasing awareness of eye health. Key companies, including Johnson & Johnson, HOYA, Alcon, Lenstec Optical Group, HumanOptics, Carl Zeiss Meditec, Bausch + Lomb, Rayner, STAAR Surgical, EyeKon, Care Group, Morcher, Ophtec, Hanita Lenses, Omni Lens Pvt Ltd, Aurolab, SIFI, PhysIOL, and Excellent Hicare Pvt Ltd, are leading innovation in this evolving landscape.

Develnsight's latest report, "Astigmatism - Market Insight, Epidemiology And Market Forecast - 2032 [https://www.delveinsight.com/report-store/astigmatism-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]", combines robust epidemiological data with market trends, competitive landscape analysis, and assessments of the patient journey, providing valuable insights into the rapidly expanding astigmatism market.

Astigmatism is a common refractive error affecting a large global population, creating a substantial demand for corrective measures and vision enhancement technologies. The astigmatism market is projected to experience steady growth in the 7MM with a robust CAGR, driven by technological advancements in vision correction methods, rising awareness about eye health, and various demographic factors such as age and genetic predisposition. While the exact genetic mechanisms are not fully understood, several studies have indicated hereditary patterns whereby astigmatism often runs in families.

Download the Astigmatism market report to understand which factors are driving the Astigmatism treatment market @ Astigmatism Market Trends [https://www.delveinsight.com/sample-request/astigmatism-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]

The astigmatism epidemiology in the DelveInsight report reveals a significant burden. Astigmatism prevalence in the general population varied from 8 to 62%, with higher rates in individuals aged 70 years or older. Furthermore, the prevalence of with-the-rule astigmatism is more significant in individuals aged 40 years or younger, while rates of against-the-rule and oblique astigmatism tend to increase with age.

Gain valuable insights into the Astigmatism patient pool across the 7MM @ Astigmatism Epidemiology Analysis [https://www.delveinsight.com/sample-request/astigmatism-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]

The report also discusses current and emerging trends in astigmatism treatment. The current treatment landscape is diverse, offering both non-invasive and surgical options tailored to the severity of the condition and patient preferences.

Non-invasive treatments remain the most common approach to managing astigmatism. Prescription eyeglasses and contact lenses, particularly toric lenses, are widely utilized to correct the uneven curvature of the cornea, providing a simple and cost-effective solution for patients.

Refractive surgeries such as LASIK and PRK are highly effective options. Another surgical alternative involves implanting intraocular lenses during cataract surgery or refractive lens exchange. These lenses offer long-term vision correction and especially benefit older patients undergoing cataract surgery.

Orthokeratology presents a non-surgical alternative for correcting astigmatism, particularly in pediatric patients or those not yet ready for surgery, using specially designed rigid contact lenses overnight to temporarily reshape the cornea.

In January 2025, the MEL 90 excimer laser by Carl Zeiss Meditec AG received U.S. FDA approval for treating myopia, hyperopia, and mixed astigmatism, marking a significant milestone in refractive surgery. Equipped with the Triple-A ablation algorithm, the MEL 90 offers highly predictable, tissue-conserving procedures and can ablate 1 diopter in just 1.3 seconds during LASIK for myopia.

Emerging therapies are transforming the astigmatism treatment landscape by offering safer, minimally invasive, and highly effective alternatives to traditional surgical procedures. These innovations promise quicker recovery times and enhanced precision, addressing unmet needs in astigmatism management.

Notable developments include the introduction of toric intraocular lenses (IOLs) specifically designed to correct astigmatism during cataract surgery or refractive lens exchange. Another emerging alternative is SMILE (Small Incision Lenticule Extraction), a flapless procedure utilizing femtosecond laser technology, which is particularly suitable for patients with dry eyes or thin corneas.

Stay ahead with the latest breakthroughs, FDA approvals, and eco-friendly innovations shaping the future of the Astigmatism treatment landscape. Visit Astigmatism Recent Developments [https://www.delveinsight.com/sample-request/astigmatism-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]

As these emerging treatments gain traction, they address key unmet needs in astigmatism management, such as minimizing visual disturbances and expanding eligibility for procedures. With ongoing research and development in areas like gene-editing technologies, such as CRISPR/Cas9, and regenerative medicine, such as stem cell therapy to regenerate damaged ocular tissues, the future of the astigmatism treatment market looks increasingly promising.

Table of contents

1.

Key Insights

2.

Executive Summary of Astigmatism

3.

Astigmatism Competitive Intelligence Analysis

4.

Astigmatism: Market Overview at a Glance

5.

Astigmatism: Disease Background and Overview

6.

Patient Journey

7.

Astigmatism Epidemiology and Patient Population

8.

Treatment Algorithm, Current Treatment, and Medical Practices

9.

Astigmatism Unmet Needs

10.

Key Endpoints of Astigmatism Treatment

11.

Astigmatism Marketed Products

12.

Astigmatism Emerging Therapies

13.

Astigmatism: Seven Major Market Analysis

14.

Attribute analysis

15.

7MM: Market Outlook

16.

Access and Reimbursement Overview of Astigmatism

17.

KOL Views

18.

Astigmatism Market Drivers

19.

Astigmatism Market Barriers

20.

Appendix

21.

DelveInsight Capabilities

22.

Disclaimer

23.

About DelveInsight

Related Reports

Dry Age-Related Macular Degeneration Pipeline Insight [https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]

Dry Age-Related Macular Degeneration Pipeline Insight provides comprehensive insights about the Dry Age-Related Macular Degeneration pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the Dry Age-Related Macular Degeneration manufacturers, including Belite Bio (NASDAQ: BLTE), Inflammx Therapeutics, Ocugen (NASDAQ: OCGN), OliX Pharmaceuticals, Gensight Biologics (NASDAQ: GNST), Alkeus Pharmaceuticals, Dobecure, Cognition Therapeutics (NASDAQ: CGTX), Aviceda Therapeutics, Galimedix Therapeutics, Mitotech (NASDAQ: MITO), Annexon, Inc. (NASDAQ: ANNX), NGM Biopharmaceuticals (NASDAQ: NGM), Johnson & Johnson, Lineage Cell Therapeutics, Astellas Pharma, Regenerative Patch Technologies, Hoffmann-La Roche, Boehringer Ingelheim, and ONL Therapeutics, among others.

About DelveInsight

DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=astigmatism-market-poised-for-robust-growth-in-the-7mm-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Astigmatism Market Poised for Robust Growth in the 7MM | DelveInsight here

News-ID: 3969808 • Views:

More Releases from ABNewswire

New Book
New Book "Faith, Journey, Testimony" Inspires Women of Faith to Embrace Their Go …
Image: https://www.abnewswire.com/upload/2025/10/62b3aa4c0771b79bb896f531c422afdc.jpg Nashville, TN - October 20, 2025 - Author and spiritual leader Prophetess Tasha Sellers announces the pre-order launch of her highly anticipated book, Faith, Journey, Testimony , a deeply personal and faith-filled collection of stories designed to uplift, heal, and empower women in their walk with God. Faith, Journey, Testimony offers an intimate look into real-life experiences of faith, transformation, and perseverance. Through heartfelt testimonies, guided reflections, and prayer prompts,
'Project 2026': A Citizen-Driven Countermovement to Reclaim America's Future
'Project 2026': A Citizen-Driven Countermovement to Reclaim America's Future
Image: https://www.abnewswire.com/upload/2025/10/ab93278043f10190dc46e150b91c3a47.jpg PROSPERITY, S.C. - Oct 20, 2025 - As Project 2025 pushes an agenda of centralized authority and top-down control, Navy veteran and historic preservation leader Michael Bedenbaugh issues a sharp rebuke in his urgent new book, Reviving Our Republic: 95 Theses for the Future of America. His message: America's survival depends on a citizen-led revolution of accountability - what he calls "Project 2026." "We have serious issues with the nation
RFE Marketing Ventures LLC Revolutionizes Trend-Based E-Commerce for Digital-Native Consumers
RFE Marketing Ventures LLC Revolutionizes Trend-Based E-Commerce for Digital-Nat …
RFE Marketing Ventures LLC transforms online shopping by rapidly bringing viral products and trending apparel to market through its sophisticated Shopify platform. The company serves tech-savvy consumers across social media platforms, offering carefully curated products ideal for personal use or gifting. The digital transformation of retail has found dynamic expression through RFE Marketing Ventures LLC, an e-commerce company that has successfully developed a business model centered on rapidly identifying and delivering
Yield Bridge Asset Management Enters into the Litigation Financing Private Credit Markets
Yield Bridge Asset Management Enters into the Litigation Financing Private Credi …
Image: https://www.abnewswire.com/upload/2025/10/ea122f978b5c0d2105e8c0889e749c39.jpg London, United Kingdom - October 20, 2025 - Yield Bridge Asset Management [http://www.yieldbridgeasset.com/] (Yield Bridge) is pleased to announce its entry into the Litigation Financing private credit markets. Senior management has signed several strategic partnerships within the international arbitration space, giving Yield Bridge ongoing access to vetted, insurance-wrapped Litigation and Private Credit asset programs. Litigation funding is no longer a marginal phenomenon - it is now a fundamental pillar of

All 5 Releases


More Releases for Astigmatism

Astigmatism Market Trends Point to Steady Growth Ahead by 2032, DelveInsight Ana …
DelveInsight's "Astigmatism Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Astigmatism, historical and forecasted epidemiology as well as the Astigmatism market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Astigmatism market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Astigmatism Market Forecast https://www.delveinsight.com/sample-request/astigmatism-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key facts of the Astigmatism Market Report:
Astigmatism Market Analysis, Epidemiology, Trends and Forecast till 2023-2033
IMARC Group has recently released a report titled "Astigmatism Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future Forecast (2023-2033)" that presents a comprehensive assessment of the astigmatism market size. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market size, and growth trends. Furthermore, the report offers an analysis
Astigmatism Market Size, Share, Classification, Opportunities, Types and Applica …
The Insight Partners has added Latest Report on Astigmatism Market To 2028. Research Report mainly includes Size, Share, growth Factors, sales, Demand, Revenue, Trade, Forecast and Global companies Analysis. To offer more clarity regarding the industry, the report takes a closer look at the current status of various factors including but not limited to supply chain management, niche markets, distribution channel, trade, supply, and demand and production capability across different countries. The
Astigmatism Market Insights Covering Market Dynamics and Competitive Scenario th …
The latest Astigmatism Market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thoroughanalysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. This study can be described as most wide-ranging documentation that comprises all the aspects of the evolving Astigmatism Market. Astigmatism comes under
Contacts for astigmatism can help vision
People with astigmatism may believe they are forced to wear glasses. Dr. Paul Super at Eye Site LA says contacts for astigmatism can help vision. The person needing the contacts just needs to get the right one. Gas-permeable contacts (GP lenses), is rigid and keeps their shape when placed on the eye. The GP lens then forces the cornea into a shape that improves vision. "These are not the same as hard
Contact Lenses for Astigmatism Industry Analysis by 2025: QY Research
Global Contact Lenses for Astigmatism Market Overview: QY Research has evaluated the global Contact Lenses for Astigmatism market in its latest research report. The research report, titled [Global Contact Lenses for Astigmatism Industry Research Report, Growth Trends and Competitive Analysis 2019-2025], presents a detailed analysis of the drivers and restraints impacting the overall market. Analysts have studied the key trends defining the trajectory of the market. The research report also includes an assessment of